Alex Sapir's Net Worth
$227 Thousand
Who is Alex Sapir?
Alex Sapir does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PhaseBio Pharmaceuticals Inc, Dova Pharmaceuticals, Inc., and Fulcrum Therapeutics, Inc..
SEC CIK
Alex Sapir's CIK is 0001709415
Past Insider Trading and Trends
2017 was Alex Sapir's most active year for acquiring shares with 2 total transactions. Alex Sapir's most active month to acquire stocks was the month of April. 2017 was Alex Sapir's most active year for disposing of shares, totalling 1 transactions. Alex Sapir's most active month to dispose stocks was the month of April. 2024 saw Alex Sapir paying a total of $982,527.60 for 193,360 shares, this is the most they've acquired in one year. In 2024 Alex Sapir cashed out on 150,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001
InvestorAlex Sapir owns 3,750 units of Common Stock which is worth $0.00. In the year 2020 Alex Sapir filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.75K |
—
|
—
| 3.75K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dova Pharmaceuticals, Inc. No price found
President & CEOAlex Sapir owns 46,909 units of Common Stock. In the year 2017 Alex Sapir filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 21.7K |
$22.83 | $495,411.00 | 21.7K |
Aug 14
| |||
Form 4
| +133.38% | 26.81K |
$3.73 | $99,997.57 | 46.91K |
Dec 22
| |||
Form 4
|
∞
| 20.1K |
$17.00 | $341,700.00 | 20.1K |
Jul 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
See RemarksAlex Sapir owns 193,360 units of Common Stock which is worth $1,651,294.40. In the year 2023 Alex Sapir acquired a total of 193,360 shares in Fulcrum Therapeutics, Inc. at a cost of $982,527.60.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +345.94% | 150K |
$3.27 | $490,500.00 | 193.36K |
Jul 3
| |||
Form 4
|
∞
| 43.36K |
$11.35 | $492,027.60 | 43.36K |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||